Global DPT Vaccines Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global DPT Vaccines market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for DPT Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for DPT Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for DPT Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of DPT Vaccines include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DPT Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Vaccines.

The DPT Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DPT Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

DPT Vaccines Segment by Company

Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology

DPT Vaccines Segment by Type

DTaP
Tdap
DTwP

DPT Vaccines Segment by Age
12 Months Below
12 Months Above

DPT Vaccines Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DPT Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of DPT Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global DPT Vaccines Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global DPT Vaccines Sales Estimates and Forecasts (2020-2031)
1.3 DPT Vaccines Market by Type
1.3.1 DTaP
1.3.2 Tdap
1.3.3 DTwP
1.4 Global DPT Vaccines Market Size by Type
1.4.1 Global DPT Vaccines Market Size Overview by Type (2020-2031)
1.4.2 Global DPT Vaccines Historic Market Size Review by Type (2020-2025)
1.4.3 Global DPT Vaccines Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America DPT Vaccines Sales Breakdown by Type (2020-2025)
1.5.2 Europe DPT Vaccines Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific DPT Vaccines Sales Breakdown by Type (2020-2025)
1.5.4 South America DPT Vaccines Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa DPT Vaccines Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 DPT Vaccines Industry Trends
2.2 DPT Vaccines Industry Drivers
2.3 DPT Vaccines Industry Opportunities and Challenges
2.4 DPT Vaccines Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by DPT Vaccines Revenue (2020-2025)
3.2 Global Top Players by DPT Vaccines Sales (2020-2025)
3.3 Global Top Players by DPT Vaccines Price (2020-2025)
3.4 Global DPT Vaccines Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global DPT Vaccines Major Company Production Sites & Headquarters
3.6 Global DPT Vaccines Company, Product Type & Application
3.7 Global DPT Vaccines Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global DPT Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 DPT Vaccines Players Market Share by Revenue in 2024
3.8.3 2023 DPT Vaccines Tier 1, Tier 2, and Tier 3
4 DPT Vaccines Regional Status and Outlook

4.1 Global DPT Vaccines Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global DPT Vaccines Historic Market Size by Region
4.2.1 Global DPT Vaccines Sales in Volume by Region (2020-2025)
4.2.2 Global DPT Vaccines Sales in Value by Region (2020-2025)
4.2.3 Global DPT Vaccines Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global DPT Vaccines Forecasted Market Size by Region
4.3.1 Global DPT Vaccines Sales in Volume by Region (2026-2031)
4.3.2 Global DPT Vaccines Sales in Value by Region (2026-2031)
4.3.3 Global DPT Vaccines Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 DPT Vaccines by Application

5.1 DPT Vaccines Market by Age
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global DPT Vaccines Market Size by Age
5.2.1 Global DPT Vaccines Market Size Overview by Application (2020-2031)
5.2.2 Global DPT Vaccines Historic Market Size Review by Application (2020-2025)
5.2.3 Global DPT Vaccines Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Age
5.3.1 North America DPT Vaccines Sales Breakdown by Age (2020-2025)
5.3.2 Europe DPT Vaccines Sales Breakdown by Age (2020-2025)
5.3.3 Asia-Pacific DPT Vaccines Sales Breakdown by Age (2020-2025)
5.3.4 South America DPT Vaccines Sales Breakdown by Age (2020-2025)
5.3.5 Middle East and Africa DPT Vaccines Sales Breakdown by Age (2020-2025)
6 Company Profiles

6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Comapny Information
6.1.2 Sanofi Pasteur Business Overview
6.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK DPT Vaccines Product Portfolio
6.2.5 GSK Recent Developments
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Comapny Information
6.3.2 Mitsubishi Tanabe Pharma Business Overview
6.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments
6.4 KM Biologics
6.4.1 KM Biologics Comapny Information
6.4.2 KM Biologics Business Overview
6.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 KM Biologics DPT Vaccines Product Portfolio
6.4.5 KM Biologics Recent Developments
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Comapny Information
6.5.2 Wuhan Institute of Biological Products Business Overview
6.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Comapny Information
6.6.2 Walvax Biotechnology Business Overview
6.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments
6.7 Chengdu Institute of Biological Products
6.7.1 Chengdu Institute of Biological Products Comapny Information
6.7.2 Chengdu Institute of Biological Products Business Overview
6.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Comapny Information
6.8.2 Minhai Biotechnology Business Overview
6.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments
7 North America by Country

7.1 North America DPT Vaccines Sales by Country
7.1.1 North America DPT Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America DPT Vaccines Sales by Country (2020-2025)
7.1.3 North America DPT Vaccines Sales Forecast by Country (2026-2031)
7.2 North America DPT Vaccines Market Size by Country
7.2.1 North America DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America DPT Vaccines Market Size by Country (2020-2025)
7.2.3 North America DPT Vaccines Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe DPT Vaccines Sales by Country
8.1.1 Europe DPT Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe DPT Vaccines Sales by Country (2020-2025)
8.1.3 Europe DPT Vaccines Sales Forecast by Country (2026-2031)
8.2 Europe DPT Vaccines Market Size by Country
8.2.1 Europe DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe DPT Vaccines Market Size by Country (2020-2025)
8.2.3 Europe DPT Vaccines Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific DPT Vaccines Sales by Country
9.1.1 Asia-Pacific DPT Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific DPT Vaccines Sales by Country (2020-2025)
9.1.3 Asia-Pacific DPT Vaccines Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific DPT Vaccines Market Size by Country
9.2.1 Asia-Pacific DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific DPT Vaccines Market Size by Country (2020-2025)
9.2.3 Asia-Pacific DPT Vaccines Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America DPT Vaccines Sales by Country
10.1.1 South America DPT Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America DPT Vaccines Sales by Country (2020-2025)
10.1.3 South America DPT Vaccines Sales Forecast by Country (2026-2031)
10.2 South America DPT Vaccines Market Size by Country
10.2.1 South America DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America DPT Vaccines Market Size by Country (2020-2025)
10.2.3 South America DPT Vaccines Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa DPT Vaccines Sales by Country
11.1.1 Middle East and Africa DPT Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa DPT Vaccines Sales by Country (2020-2025)
11.1.3 Middle East and Africa DPT Vaccines Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa DPT Vaccines Market Size by Country
11.2.1 Middle East and Africa DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa DPT Vaccines Market Size by Country (2020-2025)
11.2.3 Middle East and Africa DPT Vaccines Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 DPT Vaccines Value Chain Analysis
12.1.1 DPT Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 DPT Vaccines Production Mode & Process
12.2 DPT Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 DPT Vaccines Distributors
12.2.3 DPT Vaccines Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings